BRKR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Bruker Corp (BRKR) is not a strong buy for a beginner investor with a long-term horizon at this time. While the stock has shown slight positive momentum in the short term, the weak Q4 financial performance, lowered price targets, and lack of significant positive catalysts suggest caution. The SwingMax signal indicates a recent entry point, but given the broader context, holding off on further investment is advisable.
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 59.613, and moving averages are converging, showing no clear trend. The stock is trading near resistance levels (R1: 40.925, R2: 42.313), suggesting limited immediate upside potential.
The SwingMax signal from 2026-02-23 suggests a potential short-term swing trading opportunity with a 2.28% price increase since the signal. Net income and EPS showed YoY growth in Q4 2025.
Q4 2025 financials revealed a revenue decline (-0.24% YoY) and gross margin contraction (-9.04% YoY). Analysts have broadly lowered price targets, citing weak earnings, margins, and free cash flow. The stock lacks recent positive news or significant insider/hedge fund activity.
In Q4 2025, revenue dropped slightly (-0.24% YoY) to $977.2M. Net income increased by 8.76% YoY to $14.9M, and EPS rose by 11.11% YoY to $0.1. However, gross margin fell significantly (-9.04% YoY) to 45.97%, indicating cost pressures.
Analysts are cautious with mixed ratings. Several firms lowered price targets, citing weak Q4 results and challenging guidance. Notable ratings include a Sell from Goldman Sachs (PT: $35) and Buy ratings from BofA and Jefferies (PTs: $49 and $50, respectively).
